418
Views
23
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia

Pages 39-46 | Published online: 04 Feb 2013

References

  • PerepanovaTSKhazanPLPhytopreparation Canephron® N in the treatment and prophylaxis of urinary tract infectionsVrachebnoye Soslovie200554446
  • SinyakovaLAKosovaIVPrevention of urinary tract infection recurrencesUrologia200922225
  • ShaplyginLVMonakovDMCanephron® N for treatment and prophylaxis of urolithiasisVrachebnoye Soslovie200472224
  • RepinaMAKolchinaVAKuzmina-KrutetskayaSRStambulovaOAGolubenkoNAPhytopreparations in the treatment of renal diseases in pregnant women and long-term safety results in born childrenJournal of Obstetrics and Women’s Diseases200615056
  • OrdzhonikidzeNVYemelyanovaAIPetrovaSBComplication prevention and treatment in pregnants and puerperants with urinary tract diseasesObstetrics and Gynaecology200964145
  • VoznesenskayaTSKutafinaEKPhytotherapy in the urinary system infection treatment in childrenPediatric Pharmacology200773840
  • KirillovVIRunenkoVIBogdanovaNAMstislavskayaSAComplex therapy effects on the kidney function in children with vesicoureteral reflux in post-operative periodQuestions of Contemporary Pediatrics200763843
  • SukaloAVKrokhinaSATurNIPreparation Canephron® N use in complex therapy of urinary system infections in childrenMedical News2004118486
  • IvanovDDNazarenkoVIKushnirenkoSVKrotVFTaranEIPhytotherapy of metabolic syndrome/type II diabetes: a potential for phytoneeringHealth of the Ukraine2005174647
  • DudarIOLobodaOMKrotVFKhimichVIKryzhanivskaVMBryzhachenkoTPA 12-month comparative study of Canephron® N administration in the treatment of patients with the urinary tract infectionZdorovie Muzhchiny201038590
  • ChernenkoVVSavchukVIZheltovskaNIShtilvaserLMPeculiarities in correction of urinary pH and hypercristalluria in patients having uratolithiasis by means of phytopreparation Canephron® NZdorovie Muzhchiny200326566
  • ChernenkoVVShtilvaserLMZheltovskayaNIContemporary approaches to pro- and metaphylactics of urolithiasisUrologiya2005424
  • MedvedVIIslamovaEVTo the question on safety of the preparation Canephron® N in the obstetric practiceMedical Aspects of Women’s Health200943235
  • MedvedVIBykovaLMDanylkivOEShkabarovskayaENPathogenetic justification and efficiency of improved therapy of pyelonephritis in pregnant women with diabetes mellitusWomen’s Reproductive Health200323538
  • PotapoVADemchenkoTVMedvedevMVPathogenetic therapy of gestational toxicosis in patients with renal diseaseHealth of the Ukraine2004512
  • SeymivskyyDAPlace of phyto-medication Canephron® N in the treatment of urological diseases in childrenContemporary Pediatrics20102178181
  • CebanAEfficacy of a fixed combination of Centaurii herba, Levistici radix and Rosmarini folium in urinary lithiasis. Results of an open randomised cohort studyZ Phytother2012331923
  • GaybullaevAAKarievSSEffect of long-term Canephron® N treatment on urinary risk factors associated with idiopathic calcium urolithiasisÄrzte Zeitung online. [newspaper on the Internet]82011 Available from: http://www.aerztezeitung.de/kongresse/mwi/mwi2011-urolith/Accessed October 15, 2012 German
  • WilcoxWRKhalafAWeinbergerAKippenIKlinenbergJRSolubility of uric acid and monosodium urateMed Biol Eng1972105225315074854
  • PakCYWaterOArnoldLHoltKCoxCBarillaDMechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urateJ Clin Invest19775942643114173
  • TürkCKnollTPetrikASaricaKStraubMSeitzCGuidelines on urolithiasis22012 Available from: http://www.uroweb.org/gls/pockets/english/22_Urolithiasis.pdfAccessed October 15, 2012
  • GrabeMBjerklundJohansen TEGuidelines on urological infections32009 Available from: http://www.uroweb.org/gls/pdf/17_Urological%20infections_LR%20II.pdfAccessed October 15, 2012